A B S T R A C T Normal rabbit serum reduces the buoyant density of lipopolysaccharide (LPS) from Escherichia coli 011l:B4 (d = 1.44 g/cm3) and Salmonella minnesota R595 (d = 1.38 gem3) to a value <1.2 g/cm3. This density shift is associated with the inhibition of a number of endotoxic activities of the LPS; namely, the pyrogenic activity, the ability to produce an immediate neutropenia in rabbits, lethality in adrenalectomized mice, and anticomplementary activity. A qualitatively similar change in buoyant density was observed to occur after intravenous injection of the LPS into rabbits. Preliminary evidence suggests that the density shift does not occur as a result of the degradation of the glycolipid backbone of the LPS. These data suggest that the interactions of LPS with plasma (or serum) components leading to reduction in buoyant density may account for a major pathway of LPS detoxification.
INTRODUCTION
Direct interactions of bacterial lipopolysaccharide (LPS)i with humoral as well as cellular elements may lead to the production of injurious mediators responsible for the initiation of LPS-induced hemodynamic and coagulative changes (reviewed in 1). Therefore, the elucidation of the mechanisms of LPS-induced pathophysiologic changes may, in part, be accomplished by determining the specificity of LPS binding in the host. However, interactions of LPS with humoral, as well as cellular elements, may also lead to a progressive loss of biological activity of the LPS. This loss of activity has been termed detoxification (reviewed in 2). Thus, studies of LPS distribution in vivo designed to eluciThis is publication 1484 from Scripps Clinic and Research Foundation.
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date the pathogenic mechanism(s) of injury must also consider interactions of LPS that result in detoxification.
The mechanism of LPS detoxification that occurs in the vascular compartment is the subject of controversy and as yet, the plasma component(s) required have not been well characterized. The mechanisms proposed to account for LPS detoxification include either enzymatic degradation of LPS (2) or a "detergent-like" effect of plasma resulting in disaggregation of LPS with subsequent loss of biological activity (3) . It has also been suggested that the complement system may participate in the detoxification of LPS in plasma (4, 5) .
The studies described in this and subsequent reports examine the interaction of LPS from Escherichia coli 0111:B4 or Salmonella minnesota R595 with plasma and serum with radioiodinated preparations of0111:B4 and R595 LPS as tracer molecules. We have recently described the preparation and characterization of 1231-LPS with the following properties; (a) the radiolabel is covalently bound, (b) the specific activity is at least 2 ,uCi/,4g, and (c) the biophysical and biologic properties of the radiolabeled LPS and unlabeled LPS are indistinguishable (6) .
Experimental studies from this laboratory have shown that 0111:B4 and R595 LPS possess multiple endotoxic activities including the ability to initiate bone marrow-derived-cell mitogenesis, to stimulate murine peritoneal macrophages to become nonspecifically cytotoxic for tumor cells in vitro, to activate Hageman factor, to induce pyrogenic responses in rabbits, and to produce hypotensive shock and disseminated intravascular coagulation in rabbits and subhuman primates. Both of these LPS preparations contain a high proportion of the biologically active lipid A. However, they differ significantly in both the mechanism by which they activate complement and in their carbohydrate content. LPS 0111:B4, an activator of the alternative complement pathway, consists of lipid A, core, and o-antigen polysaccharide whereas LPS, R595, consists of lipid A and a trisaccharide of 2-keto-3-deoxyoctulosonate and activates the classical complement pathway (7).
In the studies described here we will examine the interactions of LPS with plasma (in vivo) and serum (in vitro). To do this we will characterize changes in the hydrodynamic properties of LPS induced by serum or plasma, isolate the modified LPS from LPS/serum mixtures, and study the biological activities ofthe modified LPS. In this and subsequent papers we will describe experiments that led to the formulation of the following minimal two-step scheme to explain the modifications of LPS by plasma (or serum) resulting in the detoxification of the LPS.
Step I (LPS)native + plasma factor = (LPS)modjfied
Step II (LPS)modified + high density lipoprotein (LPS)d<l12gUcma. (1) LPS with d < 1.2 g/cm3 is the detoxified form ofthe LPS.
METHODS

Rabbits
Male New Zealand white rabbits (2-2. (8) as modified by Morrison and Leive (9) . The fraction of LPS with short antigenic side chains, termed 0111:B4, fraction II was used in these experiments. The concentration of LPS was determined by measurement of the dideoxyhexose sugar, colitose, in a colorimetric assay (10 (9) . We are especially grateful to Dr. Loretta Leive (National Institutes of Health, Bethesda, Md.) for the preparation of the E. coli J5 bacteria grown in the presence of the radioactive sugars.
LPS from S. minnesota R595 was extracted according to the method of Galanos et al. (11) . This LPS consists of lipid A and a trisaccharide of 2-keto-3-deoxyoctulosonate (KDO). The presence of KDO was assayed for colorimetric assay by a modification (9) of the thiobarbituric acid assay of Cynkin and Ashwell (10) . Solubilized preparations of R595 LPS were prepared by sonication of a 5-mg/ml LPS solution in the presence of 0.1% triethylamine followed by dialysis against sterile saline at 4°C. Radioiodinated 0111:B4 or R595 LPS was prepared according to the method of Ulevitch (6) . 125I-LPS with a specific activity between 2 and 5 ZCi/4tg was employed for the experiments described in this paper. This material was stored at 4°C in the presence of 0.01% sodium azide. For some experiments LPS was radiolabeled with Na131I (6).
Serum
Whole blood was collected from the medial ear artery of rabbits, allowed to clot in a glass tube for 60 min, 37°C and the serum removed after centrifugation at 10,000 g for 30 min 4°C. Serum from at least six rabbits was pooled, aliquoted, and stored at -70°C until needed. Frozen serum was thawed at 37°C and employed immediately for experiments described in this paper.
Analytical techniques to study LPSlserum interactions Ultracentrifugation. Isopycnic density gradient ultracentrifugation was performed with CsCl solutions of an average d of 1.28 or 1.4 g/cm3 as previously described (9) . Samples were centrifuged to equilibrium in the Spinco model L-2 preparative ultracentrifuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) with the SW 50.1 rotor, 40,000 rpm for at least 48 h at 4°C, fractions collected (0.10 ml per fraction) and the densities calculated from the index of refraction with a refractometer.
Effect ofLPS on core temperature and levels of circulating polymorphonuclear cells. Changes in core temperature induced by LPS injection were monitored with a model 44TH telethermometer from Yellow Springs Instrument Co., Yellow Springs, Ohio. Base-line temperatures were recorded for 1 h before LPS injection. Levels of peripheral blood polymorphonuclear cells were determined as previously described (12) .
Lethality studies in mice. Adrenalectomized BALB/c AnCr mice (8-10 wk, 18-22 g ) were used to determine the median lethal dose of either native LPS or serum altered LPS. Mice were anesthetized with ether, adrenalectomized, and allowed to recover for 24 h before use. Normal saline was substituted for drinking water for adrenalectomized mice. Sham operated and normal animals were also included in the study. Dilutions of the test samples were prepared in sterile saline and 0.2 ml samples injected into the tail vein. At least five mice were used for each concentration of LPS tested. Survivors were counted 24 h after injection and the data analyzed by the method of Reed and Meunch (13) .
Complement activation. The measurement of serum hemolytic complement was performed as previously described (14) . To compare the anticomplementary activity of native or serum-altered LPS we performed the following experiment. Pooled normal rabbit serum stored at -70°C was thawed at 370C and equal volumes of the LPS sample and the serum were incubated for 30 min at 37°C. This solution was diluted (usually 1:15) and the total hemolytic complement remaining determined.
Sodium dodecyl sulfate (SDS) gel electrophoresis. 0.6 x 15 cm 12.5% polyacrylamide gels that contained 0.1% SDS and 8-M urea were prepared as described by Downer et al. (15) with two modifications. The final concentration of N,N,N',N'-tetramethylenediamine used was 1.7,ul/ml stock gel solution and polymerization was initiated with 0.5 mg/ml gel solution of ammonium persulfate. Experimental samples (up Increasing amounts of unlabeled LPS were added to a constant amount of '25I-0111:B4 LPS to determine the capacity of NRS to effect the density shift. When 60 ,ug of 0111:B4 LPS is added to 1 ml of NRS (75% vol/vol) as described above -80% of the LPS appears at a d < 1.2 g/cm3. Final 011l:B4 LPS concentrations in excess of 60 ,ug LPS/ml of NRS (75%) result in accumulation of LPS intermediates with d > 1.2 g/cm3.
The ability of serum to modify the endotoxic activity of LPS has previously been shown to be markedly enhanced by the addition of chelators of divalent ions (18, 19) . We therefore examined the effect of EDTA on the ability of NRS to alter the buoyant density of 0111:B4 LPS. Experiments were performed with 0111:B4 LPS and NRS that contained 10mM EDTA (pH 7.5) exactly as described above. The kinetics of the NRS-induced alteration in the buoyant density of 0111:B4 were not enhanced or inhibited by prior addition of 10 mM EDTA to the NRS.
Interaction of R595 LPS with serum The effect of NRS on the buoyant density of R595 LPS was next examined. This LPS consists of only lipid A and a trisaccharide of KDO and is therefore >90% lipid A. The hydrated buoyant density of R595 LPS is 1.38 g/cm3 and as shown in Fig. 2a The prsneo0de,ulble S5LSwsdt 4ie byd asay fo0Dn,hserslsaesow ytedse as described above. Data from CsCl gradients for the 125I-R595-LPS before and at 1, 5, and 60 min after the addition of NRS are shown in Fig. 2 . The reaction is essentially complete within 1 min after the addition of R595 LPS to serum. As shown in Fig. 2a the native R595 LPS has a hydrated buoyant density of 1.38 g/cm3 and after the addition of serum a new peak appears at a d < 1.2 g/cm3 (Fig. 2b-d) . The predominance of the radioactivity remains at a d = 1.38 g/cm3 and even after 60 min only 25% of the added radioactivity is found at d < 1.2 g/cm3. No intermediates between d = 1.38 g/cm3 and d < 1.2 g/cm3 were observed. These data demonstrate that NRS can also produce a decrease in the buoyant density of R595 LPS, although the extent ofthis reaction is not as great as observed with 0111:B4 LPS.
We also examined the effect of prior addition of 10 mM EDTA on the interactions of R595 with serum. The experiment was performed exactly as described above except that the NRS contained 10 mM EDTA. The addition of EDTA was observed to markedly increase the amount of R595 LPS shifted to d < 1.2 g/cm3. Within 1 min of incubation with NRS that contained 10 mM EDTA greater than 75% of the added LPS was found to band at a d < 1.2 g/cm3. Representative data from CsCl gradients of R595 at 1 and 60 min after addition to EDTA-serum are shown in Fig. 3 . Therefore in a marked contrast to experiments with 0111:B4 LPS, the prior addition of EDTA markedly enhances the NRS induced modifications of R595 LPS. In the presence of 10 mM EDTA, 1 ml of NRS (75% vol/vol), will convert at least 100 Zg to R595 LPS to a buoyant density of <1.2 g/cm3.
Because ofthe possible direct effect of EDTA on R595 LPS we incubated R595 LPS with 10 mM EDTA at 37°C. This pretreatment of R595 LPS with 10 mM E DTA followed by dialysis to remove EDTA was not sufficient to support the enhanced serum induced density shift observed when EDTA was added to NRS. Further the EDTA-treated R595 LPS banded in the same position as "native" R595 LPS in CsCl gradients.
Isotope dilution experiment
To further insure that the unlabeled and the radioiodinated LPS behave in an identical manner when added to NRS the following experiment was performed with OHll:B4 LPS. We first showed that the initial rate of the density shift was dependent upon the concentration of the added LPS up to a final concentration of 12.5 ,g 0111:B4 LPS/ml of NRS (75%).
No further increase in the initial rate of the density shift was observed when concentrations greater than 12.5 ug LPS/ml NRS were employed. We also demonstrated that the rate of the density shift was essentially linear during the first 15 min of the reaction. Table I . Over the range tested the amount of LPS shifted in 12 min at 37°C was independent of the ratio of 125I-LPS:total LPS added. These data lend support to the proposal that the 125I-LPS and the unlabeled LPS interact with serum in an identical manner. Other experimental evidence supporting this conclusion will be presented in a subsequent section in which the mechanism of the density shift is examined.
In vivo alteration of LPS We next sought to determine if the density shift of LPS induced by serum also occurred in vivo. To do this we injected a mixture of radioiodinated and unlabeled Fig. 5 and as shown at least 85% of the radioactivity present in the gradient is at d < 1.2 g/cm3. No radioactivity was detected in the density region between 1.44-1.2 g/cm3 suggesting the absence of unmodified LPS in these preparations.
The concentration of LPS was determined from measurements of radioactivity based upon the specific activity of the added LPS, e.g. 125I R595 LPS. We also centrifuged NRS in an identical manner to obtain a fraction of serum proteins at a d < 1.2 g/cm3 to be employed for control studies because the low density LPS peak also contains serum proteins with a buoyant density of <1.2 g/cm3. Up to 10 mg of either LPS preparation was processed by this method and recoveries of LPS at a d < 1.2 g/cm3 ranged between 40 and 60% after the second centrifugation.
Biological activity of LPS with d < 1.2 glcm3
Experiments to compare the endotoxic activity of native and serum-altered LPS were next performed, with OHll:B4 or R595 LPS with d < 1.2 g/Cm3 isolated from LPS/serum mixtures as described above. Ultracentrifugation of saline solutions of either OHll:B4 or R595 first in KBr, then in CsCl, as described above and finally recovering the native LPS after dialysis did not alter the biological properties of the LPS. Purified LPS, treated in this manner, was employed to measure the endotoxic activity of native LPS in the assays described below. We chose to use several assays which are sensitive indicators ofthe presence of native 011l:B4 or R595 LPS. These are (a) the pyrogenic response to LPS in rabbits, (b) the ability to produce an immediate neutropenia in rabbits, (c) toxicity in adrenalectomized mice, and (d) the ability to activate the classical pathway of complement. The results of these studies are described below.
Pyrogenic response and immediate neutropenia. We first determined that the intravenous injection of 50 ng of native 0111 :B4 LPS routinely produced a biphasic rise of at least a 1-1.5°C in core temperature over a 5-h period. This amount of 01l1:B4 LPS also produced an immediate neutropenia in the rabbits with at least 90% of the circulating neutrophils being removed from the circulation with 5 min of LPS injection. These data were used for calculations of the extent of the loss of the activity in 011:B4 LPS associated with the decrease in buoyant density.
Rabbits were injected with either 5 Mug of native or low-density LPS and the temperature was measured during a 5-h period. The results of this experiment are shown in Fig. 6 and demonstrate that the low-density form of the 011l:B4 LPS was markedly inhibited in the ability to induce a pyrogenic response in rabbits. We also measured the levels of circulating neutrophils in rabbits injected with 5 ug of either native or the low-density form of 011l:B4 LPS. The immediate neutropenia induced by 011l:B4 LPS did not occur when the low-density form of LPS was injected. These data are shown in Fig. 7 . Because as little as 50 ng of LPS (d = 1.44) produces a pyrogenic response as well as neutropenia, we can conclude that no more than 1% of both the pyrogenic and neutropenia-inducing activity of native 011l:B4 remains with the LPS at d < 1.2 gI cm3. The pyrogenic activity and the ability to induce a neutropenia in rabbits characteristic of native R595 LPS were also inhibited as a result of the reduction in buoyant density.
Toxicity in adrenalectomized mice. We next compared the toxicity of native Anticomplementary activity. R595 LPS has been shown to activate the classical pathway of complement (7) . To further study the effect of the serum-induced density reduction on the endotoxic activity of R595 LPS we compared the anticomplementary activity of the low-density R595 LPS and native LPS. For this experiment we added different amounts ofeither native or serum-altered R595 LPS to normal rabbit serum, incubated these solutions at 370 and subsequently determined the level of hemolytic complement remaining as described in Methods. The amount of native R595 LPS required to reduce the hemolytic complement level 50% is 0.052 ug whereas at least 1.30 ,ug of the serum-altered R595 LPS is required to achieve a 50% reduction. The results of these experiments shown in Fig. 8 
Mechanism of serum-induced density shift
We next sought to determine if the density shift resulted from an alteration in the structure of LPS produced by significant degradation ofthe glycolipid backgone. For example enzymatic hydrolysis ofthe ketosidic linkage between the KDO and the lipid A, resulting in the release of free lipid A, might account, in part, for the density shift observed. Two different experimental approaches were used in this preliminary examination ofthe mechanism ofthe serum-induced density shift.
In one approach we employed SDS/urea polyacrylamide gel electrophoresis to examine the size of the "subunits" of 011I:B4 LPS or R595 LPS before and after the addition of the LPS to NRS. The resolution of bacterial lipopolysaccharides into fractions of different electrophoretic mobility in the presence of SDS has previously been reported (20) .
A preparation of 1251-R595 or 1251-0111:B4 LPS was added to NRS so that at least 80% of the added LPS would be banded at a d < 1.2 g/cm3 by CsCl density ultracentrifugation. The LPS/serum samples were centrifuged in CsCl and the low-density form of each LPS was pooled from individual gradients and dialyzed to remove free CsCl. A 100-,ul sample of the low-density form of 011l:B4 or R595 LPS was added to 100 ,ul of 10% SDS, 8-M urea followed by the addition of an aliquot of the appropriate native 131I-LPS. The samples were brought to 1000C for 15 min and electrophoresed and analyzed as described Methods. These results, shown in Fig. 9 for 011l:B4 LPS (top) and R595 LPS (bottom), demonstrate that the electrophoretic mobility of the native LPS, e.g. 131I-LPS, and the serum-altered LPS, e.g., 125I-LPS are identical. At least 85% of the added radioactivity were recovered in the individual gel slices for both 1251_ or 31I-labeled R595 or 0111:B4 LPS. These data suggest that enzymatic degradation of the glycolipid backbone of LPS is not a likely mechanism to account for the density shift obtained for 01 3H-:14C-ratio suggesting that no major degradation of the glycolipid backbone occurs.
Although not shown here we also determined that the rate of the density shift of 011l:B4 LPS produced by NRS at 37°C was identical when 12510L11:B4 LPS and [3H], [14C]o111:B4 LPS were compared. These data further support the conclusion that the 125I-LPS and unlabeled LPS behave in an identical way when added to NRS.
DISCUSSION
These experiments demonstrate that normal rabbit serum can produce a marked reduction in the buoyant density of 011l:B4 as well as R595 LPS. This modification results in the loss of several endotoxic activities of native LPS, namely LPS-induced pyrogenicity, neutropenia induction, toxicity, and anticomplementary activity. We further showed that an identical decrease in the buoyant density of 011l:B4 as well as R595 LPS occurs after i.v. injection into rabbits. Therefore it appears that modification ofthe LPS by plasma (or serum) components resulting in a marked decrease in the buoyant density of the LPS may account for a major intravascular pathway of LPS detoxification.
LPS detoxification by serum has been studied by a number of investigators including Skarnes (2), Rudbach and Johnson (3) , and Johnson and co-workers (4, 21) . Previous studies have focused primarily on the characterization of the serum components involved, and to date, markedly differing data regarding the nature of the serum components responsible for LPS detoxification have been presented. For example Johnson et al. (21) have recently described the purification of an a-globulin capable of inactivating LPS. These authors indicate that this protein is neither a lipoprotein nor a serine esterase. In contrast, Skarnes has suggested that two a-globulins, both of which possessed nonspecific esterase activity and one of which was a lipoprotein are responsible for LPS detoxification (16, 17) . Other studies (4, 5) The data would be consistent with the proposal that the core and 0-antigen polysaccharides of 0111:B4 LPS may stabilize this LPS and retard the rate of one or more of the serum-induced modifications required for the density shift. Experimental studies demonstrating a stabilizing effect of polysaccharide-polysaccharide interactions have been described (23) . This possibility is currently under investigation.
In experiments not presented in this paper we also determined that normal human and normal mouse sera were qualitatively indistinguishable from NRS in the capacity to produce the density reduction of 0111:B4 as well as R595 LPS.3 Because the modifications of these two different LPS preparations can occur in serum derived from at least three different sources we conclude that the density reduction may be a general mechanism for modifying the endotoxic activity of LPS in serum (or plasma).
Evidence was also presented here which demonstrated the occurrence of the time-dependent reduction in the buoyant density of 0111:B4 as well as R595 LPS in vivo. The in vivo reduction in the buoyant density of LPS appears to be at least qualitatively similar to that observed with serum, in vitro. This similarity suggests that the participation of fibrinogen or other coagulation components is not required for the reduction in buoyant density of the LPS. 3Ulevitch, R. Unpublished data.
Biological activity of serum-modified LPS. The low-density form of LPS was isolated from serum/LPS mixtures by equilibrium density ultracentrifugation.
The fraction of modified LPS tested was shown to be devoid of any material with a d > 1.2 g/cm3.
We demonstrated that the reduction in the buoyant density of 0111:B4 as well as R595 LPS results in the loss of several sensitive indicators of endotoxic activity. The ability of serum to abrogate the pyrogenic activity of LPS has been well documented and our findings are in good agreement with previously published reports (3, 24, 25) . The abrogation by serum of the ability of LPS to induce a neutropenia has not been previously described.
In contrast to the complete inhibition ofthe pyrogenic response and neutropenia induction, the toxicity of the LPS was only partially diminished as a result of the density reduction. Skames and his co-workers (2, 16, 17) have previously described a two-step mechanism for LPS detoxification which requires the participation of at least one lipoprotein. The mechanism proposed by Skames to account for the inactivation of LPS involves enzymatic degradation ofthe LPS. However direct experimental evidence to support this mechanism has yet to be presented. Recently Johnson et al. (21) have described the isolation of an LPS inactivator from human serum which appears to detoxify the LPS by disaggregation. These authors concluded that enzymatic degradation or modification of the LPS does not accompany the action of the LPS inactivator they have isolated. At present the relationship of the inactivator described by these investigators to that of the present study is uncertain.
In the present study, our results failed to support the hypothesis that enzymatic degradation of LPS accompanied serum-or plasma-induced detoxification of the LPS. Specifically the electrophoretic mobility in SDS of serum-altered R595 or 0111:B4 LPS (d < 1.2 g/cm3) was unchanged when compared to the electrophoretic mobility in SDS of native LPS (Fig. 9 ). These peaks of radioactivity displayed on SDS polyacrylamide gels have been shown to correspond exactly to carbohydrate-containing species of 011l :B4 or R595 LPS after treatment of duplicate gels with periodic acid and subsequent staining with Schiff's reagent. The technique of electrophoresis of LPS in SDS has been shown to resolve LPS into subunits. Further, the electrophoretic mobility of the subunits has been shown to be a function of the amount of lipid A (20) . The larger the ratio of lipid A:total LPS, (wtlwt), the farther the LPS will migrate into an SDS gel. Therefore if the density shift occurred as a result of the degradation of the glycolipid backbone an alteration in the electrophoretic mobility of the LPS subunits would be observed. Because we did not observe any alteration in electrophoretic mobility and because the recoveries of total radioactivity added to each gel were at least 85% of that added we conclude that no degradation occurred.
The size heterogeneity of LPS has been previously described for LPS from E. coli F492 and Citrobacter 393 (20) . The chemical characteristics of the two peaks of radioactivity detected for 0111:B4 LPS are currently under investigation. The behavior of R595 LPS in the SDS/urea gel system is similar to that reported for LPS from a rough strain of E. coli F470 (20) .
More compelling evidence for a mechanism of the density shift which does not require enzymatic deg- A more detailed analysis of the mechanism of the density shift is in progress. Preliminary evidence has been obtained with antiserum prepared against native 0111 :B4 or R595 LPS which demonstrates that the native and the serum-altered LPS are immunologically identical. Because the major antigens are believed to be contained in the carbohydrate-containing portions of the molecule these data would further support the proposal that enzymatic degradation of the LPS does not account for the density reduction.
The species of 011l:B4 LPS with buoyant density between 1.35-1.41 g/cm3 after exposure to plasma or serum (Figs. 1, 4) is of considerable interest and is under current investigation. In preliminary studies, conversion to the intermediate form was found to be essential for eventual transformation to the low-density form of LPS. Tests of the intermediate form of the LPS for pyrogenic activity in rabbits have shown them to be at least as effective as native 0111:B4 LPS (d = 1.44 g/cm3). We believe these intermediates to represent a modified form of the LPS necessary to complete the interactions leading to the density shift, but not producing a loss of biological activity. The question of serum-induced modification ofthe LPS, before the density shift will be considered in a subsequent publication.4
